Israel Englander V Tv Therapeutics Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.72 - $1.01 $14,609 - $20,493	-20,291 Reduced 31.67%	43,787 $35,000
Q4 2022 Feb 14, 2023	SELL	$0.66 - $1.02 $8,752 - $13,526	-13,261 Reduced 17.15%	64,078 $42,000
Q3 2022 Nov 14, 2022	SELL	$0.65 - $1.37 $39,873 - $84,041	-61,344 Reduced 44.23%	77,339 $75,000
Q2 2022 Aug 15, 2022	BUY	$0.39 - $0.84 $5,789 - $12,469	14,845 Added 11.99%	138,683 $104,000
Q1 2022 May 16, 2022	SELL	$0.51 - $1.0 $11,492 - $22,535	-22,535 Reduced 15.4%	123,838 $89,000

Q4 2021 Feb 14, 2022	SELL	$0.95 - $1.69 $422 - $752	-445 Reduced 0.3%	146,373 $146,000
Q3 2021 Nov 15, 2021	SELL	$1.53 - $2.22 $226,138 - $328,122	-147,803 Reduced 50.17%	146,818 $225,000
Q2 2021 Aug 16, 2021	BUY	$2.27 - $3.44 $640,158 - $970,107	282,008 Added 2235.85%	294,621 $672,000
Q1 2021 May 17, 2021	BUY	$1.97 - $2.89 $24,847 - $36,451	12,613 New	12,613 $36,000
Q4 2020 Feb 16, 2021	SELL	$1.49 - $3.1 $33,712 - $70,140	-22,626 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.7 - $2.98 $38,464 - $67,425	22,626 New	22,626 $40,000
Q2 2020 Aug 14, 2020	SELL	$1.74 - $3.19 $84,972 - $155,783	-48,835 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$1.63 - $3.75 $79,601 - $183,131	48,835 New	48,835 $93,000
Q4 2019 Feb 14, 2020	SELL	$1.37 - $1.97 $14,386 - $20,686	-10,501 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.26 - $1.77 $55 - $77	-44 Reduced 0.42%	10,501 $16,000
Q2 2019 Aug 15, 2019	SELL	$1.29 - $1.83 $4.42 Million - $6.27 Million	-3,423,762 Reduced 99.69%	10,545 $15,000
Q2 2019 Aug 14, 2019	BUY	$1.29 - $1.83 $4.42 Million - $6.26 Million	3,423,306 Added 31118.13%	3,434,307 $15.1 Million
Q1 2019 May 14, 2019	BUY	$1.67 - $3.12 $1,170 - $2,187	701 Added 6.81%	11,001 $19,000
Q4 2018 Feb 14, 2019	SELL	$0.78 - $3.74 $3,547 - $17,009	-4,548 Reduced 30.63%	10,300 $27,000
Q3 2018 Nov 14, 2018	SELL	$0.7 - $1.58 $7,876 - $17,778	-11,252 Reduced 43.11%	14,848 $11,000
Q2 2018 Aug 14, 2018	SELL	$0.71 - $4.04 $48,941 - $278,481	-68,931 Reduced 72.54%	26,100 $40,000
Q1 2018 May 15, 2018	BUY	$3.91 - $7.83 $126,535 - $253,394	32,362 Added 51.64%	95,031 $387,000
Q4 2017 Feb 14, 2018	BUY	$3.9 - $7.77 $244,409 - $486,938	62,669	62,669 $377,000

Others Institutions Holding VTVT

# of Institutions

Shares Held

243K

Call Options Held

Put Options Held

Pathstone Family Office, LLC Englewood, NJ

243K
Shares

$4.27 Million
0.0% of portfolio

View Full List

About vTv Therapeutics Inc.

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

More about VTVT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account